FDA Investigator Michael J Kuchta

Michael J Kuchta has inspections in 8 countries as of 18 Sep 2023. Michael J Kuchta has collaborated with a combinined 3325 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
103
Last Inspection Date:
18 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Netherlands, United Kingdom of Great Britain and Northern Ireland, Colombia, Italy, Ireland, Argentina, Brazil
Co-Investigator(s):
Alan P Kurtzberg, Anastasia M Shields, Andrea S Heise, Andrew M Kolenc, Anita Narula, PhD, Anita R Michael, Anthony J Lagreca, Ashleigh P Barkans, Ashleigh P Wodushek, Azza Talaat, Betty K Baxter, Blake R Jensen, Brent W Higgs, Bryan A Galvez, Bryan J Love, Bryce A Hammer, Carla J Lundi, Carla R Hinz, Carlos Chavez, Caroline H Le, Carolyn J Cook, Caryn M Mcnab, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Chani Broner, PhD, Chelsea N Sealey, Christine I Shaw, Christopher M Jenner, Cynthia Jim, CSO, Daniel J Lahar, Daniel Pst Laurent, Deborah S Hammond, Debra I Love, Debra L Curtis, Dianna D Wardlow Dotter, Dogbeda F Mackenzie, Dongping Dai, PhD, Dr. Carmelo Rosa, Dr. Gang Wang, PhD, Dr. Sriram Subramaniam, PhD, Dustin M James, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Erika V Butler, Erma Zaimova, Esther C Broner, PhD, Frank L Cordova, Frederic W French, III, Frederick L Fricke, Genoula K Ryan, Gerard T Schneider, Ginger M Sykes, Gloria A Milster, Grace E Mcnally, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Heriberto Negron Rivera, Isabel Y Espinosa, Ismael Olvera, IV, Ivis L Negron, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James R Montero, Jamie L Dion, Janet Pulver, Jennifer L Wolfe, Jessie E Morris, Joanne Heim, Joel D Hustedt, Joey V Quitania, John A Gonzalez, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Juan A Morales, Julia D Cartwright, Justin R Carr, Karen A Wolnik, Karen G Hirshfield, Katherine Szestypalow, Kelly D Moore, Kenneth V Miller, Kent C Faul, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kimberley A Hoefen, Kimetha A King, Kristen E Szenderski, Larisa E Pavlick, Larry Gehring, Lequita M Mayhew, Lewis K Antwi, Linda F Murphy, Linda M Cheny, Lori A Carr, M Patriciaurphy Murphy, Marc A Jackson, Jr, Marcus F Yambot, Margaret M Annes, Marie Bbuen Bigornia, Marijo B Kambere, PhD, Marion W Nadeau, Mariza M Jafary, Marlene G Swider, Matthew J Gretkierewicz, Matthew J Hansen, Matthew M Vernon, Matthew R Clabeaux, Matthew R Dionne, Melba Trivera Clavell, Melissa F Chauvin, Michael A Charles, Michael E Maselli, Michael Kuchta, Michael R Goga, Michael S Araneta, Michele L Obert, Miguel A Martinez, Mihaly S Ligmond, Monica E Caphart, Mra Mcculloughj, Nalini D Lebzelter, Nancy G Schmidt, Nathan M Jornod, Nayan J Patel, Neira Acevedo Ramos, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia M Jacobs, Paul M Chefor, Paul Z Balcer, Paula A Trost, Penny H Mccarver, Prabhu P Raju, Rafael Nevarez Nieves, Ramesh Raghavachari, Randy V Bong, Rebecca H Lee, Ricki A Chase, Ricki Achase Off, Robert M Barbosa, Robert Sharpnack, Roger F Zabinski, Roger L Farmer, Saied A Asbagh, Sandra A Hughes, Santiago Gallardo Johnson, Shelley H Beausoleil, Shererk, Sidney B Priesmeyer, Stephen J Koniers, Stephen T Hansen, Steve Y Rhieu, PhD, Steven C Madzo, Steven D Kehoe, Susan F Laska, MS, Susan L Young, Susan M Jackson, Tamil Arasu, PhD, Tara L Breckenridge, Tara L Greene, Teena H Aiken, Tenzin Jangchup, Teresa I Navas, Thai T Duong, Theressa B Smith, Tomika L Bivens, Uduak M Inokon, Vicky L Cruz, Virginia L Sheldon, Wayne W Grundstrom, Wdouglas Rowe, William J Leonard, Xiaoping Guan, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more